India’s Bharat Biotech says vaccine 93.4% effective against severe COVID-19
Phase-III trials of a vaccine made by India's Bharat Biotech showed it was 93.4% effective against severe symptomatic COVID-19, the ...
- Latest
- Trending
Phase-III trials of a vaccine made by India's Bharat Biotech showed it was 93.4% effective against severe symptomatic COVID-19, the ...
A COVID-19 vaccine developed by India’s Bharat Biotech is safe and has shown high levels of antibody response in a ...
Bharat Biotech’s vaccine showed 81% efficacy in preventing symptomatic COVID-19 in an interim analysis of a late-stage trial in India, ...
Brazil’s Health Ministry on Thursday signed a contract to purchase 20 million doses of Covaxin, the COVID-19 vaccine made by ...
A man rides his motorbike past a parked bus of India's biotechnology company Bharat Biotech outside its office in Hyderabad, ...
India’s Bharat Biotech submitted on Thursday an application for the emergency use of its COVID-19 vaccines in the Philippines, Food ...
